amlodipine
Cardiovascular system (C09)Cardiovascular system (C09) compound in Zentiva k.s's portfolio. Mechanism: Voltage-gated L-type calcium channel blocker.
- Mechanism
- Voltage-gated L-type calcium channel blocker
pharma
Zentiva k.s
Zentiva k.s.
Zentiva k.s drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Praha 10, CZ HQ
1488 Founded
3,631 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Praha 10, CZ
- Founded
- 1488
- Employees
- 3,631
- Programs
- 1
- Drugs
- 3
- Patents
- 0
Zentiva k.s pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Zentiva k.s drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved.
-
Development asset linked to Zentiva k.s in public FDA and regional records.